Related references
Note: Only part of the references are listed.2019 FDA TIDES (Peptides and Oligonucleotides) Harvest
Danah Al Shaer et al.
PHARMACEUTICALS (2020)
Production, characterization, and in vivo half-life extension of polymeric IgA molecules in mice
T. Noelle Lombana et al.
MABS (2019)
Evaluation and use of an anti-cynomolgus monkey CD79b surrogate antibody-drug conjugate to enable clinical development of polatuzumab vedotin
Dongwei Li et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Dual-Isotope Cryoimaging Quantitative Autoradiography: Investigating Antibody-Drug Conjugate Distribution and Payload Delivery Through Imaging
Ohad Ilovich et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Standing by for Bystander Effects: Dual-Isotope Imaging of Antibody-Drug Conjugate and Payload Distribution
Cornelius Cilliers et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
The return of gemtuzumab ozogamicin: a humanized anti-CD33 monoclonal antibody-drug conjugate for the treatment of newly diagnosed acute myeloid leukemia
Pamela C. Egan et al.
ONCOTARGETS AND THERAPY (2018)
Linkers Having a Crucial Role in Antibody-Drug Conjugates
Jun Lu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Antibody-drug conjugates for cancer therapy
Anish Thomas et al.
LANCET ONCOLOGY (2016)
Peripheral neuropathy with microtubule inhibitor containing antibody drug conjugates: Challenges and perspectives in translatability from nonclinical toxicology studies to the clinic
Nicola J. Stagg et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2016)
Current ADC Linker Chemistry
Nareshkumar Jain et al.
PHARMACEUTICAL RESEARCH (2015)
CYP3A-Mediated Drug-Drug Interaction Potential and Excretion of Brentuximab Vedotin, an Antibody-Drug Conjugate, in Patients With CD30-Positive Hematologic Malignancies
Tae H. Han et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2013)
ADME of Antibody-Maytansinoid Conjugates
Hans K. Erickson et al.
AAPS JOURNAL (2012)
Catabolic Fate and Pharmacokinetic Characterization of Trastuzumab Emtansine (T-DM1): an Emphasis on Preclinical and Clinical Catabolism
Ben-Quan Shen et al.
CURRENT DRUG METABOLISM (2012)
Impact of Drug Conjugation on Pharmacokinetics and Tissue Distribution of Anti-STEAP1 Antibody-Drug Conjugates in Rats
C. Andrew Boswell et al.
BIOCONJUGATE CHEMISTRY (2011)
Gemtuzumab ozogamicin in non-acute promyelocytic acute myeloid leukemia
Marie-Luise Huetter et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)
Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data What have we learned?
Rong Deng et al.
MABS (2011)
Antibody-Drug Conjugates for the Treatment of Non-Hodgkin's Lymphoma: Target and Linker-Drug Selection
Andrew G. Polson et al.
CANCER RESEARCH (2009)
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
SO Doronina et al.
NATURE BIOTECHNOLOGY (2003)